Effects of over- and under-expression of Cu,Zn-superoxide dismutase on the toxicity of glutamate analogs in transgenic mouse striatum

[1]  D. Price,et al.  Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Korkotian,et al.  Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Beal,et al.  Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury , 1996, Nature Genetics.

[4]  L. Greene,et al.  Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  I. Kola,et al.  Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. , 1996, Human molecular genetics.

[6]  D. Bredesen,et al.  Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.

[7]  P. Mecocci,et al.  Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  C. Epstein,et al.  3‐Nitropropionic Acid Neurotoxicity Is Attenuated in Copper/Zinc Superoxide Dismutase Transgenic Mice , 1995, Journal of neurochemistry.

[9]  J. Coyle,et al.  Mice Transgenic for Copper/Zinc Superoxide Dismutase Exhibit Increased Markers of Biogenic Amine Function , 1995, Journal of neurochemistry.

[10]  C. Epstein,et al.  CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA) , 1994, Brain Research.

[11]  C. Epstein,et al.  Rapid Communication: Attenuation of Methamphetamine‐Induced Neurotoxicity in Copper/Zinc Superoxide Dismutase Transgenic Mice , 1994, Journal of neurochemistry.

[12]  Jun Chen,et al.  Human Copper‐Zinc Superoxide Dismutase Transgenic Mice Are Highly Resistant to Reperfusion Injury After Focal Cerebral Ischemia , 1994, Stroke.

[13]  C. Epstein,et al.  Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. , 1993, Neuroreport.

[14]  D. Bredesen,et al.  Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.

[15]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[16]  J. Coyle,et al.  Kainic acid-induced lipid peroxidation: protection with butylated hydroxytoluene and U78517F in primary cultures of cerebellar granule cells , 1993, Brain Research.

[17]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[18]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[19]  A. Williams,et al.  An investigation into the role of reactive oxygen species in the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity using neuronal cell lines. , 1993, Biochemical pharmacology.

[20]  J S Beckman,et al.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. , 1992, Archives of biochemistry and biophysics.

[21]  J S Beckman,et al.  Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. , 1992, Archives of biochemistry and biophysics.

[22]  C. Epstein,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  P. Wood,et al.  A Review of in vivo modulation of cerebellar cGMP levels by excitatory amino acid receptors: role of NMDA, quisqualate and kainate subtypes , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[24]  Y. Groner,et al.  Gene dosage of CuZnSOD and Down's syndrome: diminished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice. , 1991, The EMBO journal.

[25]  D. Inzé,et al.  Manganese superoxide dismutase can reduce cellular damage mediated by oxygen radicals in transgenic plants. , 1991, The EMBO journal.

[26]  C. Epstein,et al.  Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc-superoxide dismutase. , 1990, Stroke.

[27]  T. Murphy,et al.  Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  J. Coyle,et al.  Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins , 1990, Experimental Neurology.

[29]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Murphy,et al.  Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. , 1989, The Journal of pharmacology and experimental therapeutics.

[31]  I. Fridovich.  Superoxide dismutases: an adaptation to a paramagnetic gas , 1989 .

[32]  T. Lanthorn,et al.  Experimental ischemia induces a persistent depolarization blocked by decreased calcium and NMDA antagonists , 1989, Neuroscience Letters.

[33]  J. Coyle,et al.  Down syndrome, Alzheimer's disease and the trisomy 16 mouse , 1988, Trends in Neurosciences.

[34]  O. Elroy-Stein,et al.  Impaired neurotransmitter uptake in PC12 cells overexpressing human Cu/Zn-superoxide dimutase-implication for gene dosage effects in down syndrome , 1988, Cell.

[35]  M. Lovett,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[37]  T. Tsukamoto,et al.  Disposition of idebenone (CV-2619), a new cerebral metabolism improving agent, in rats and dogs. , 1985, Journal of pharmacobio-dynamics.

[38]  M. Nirenberg,et al.  Markers for gene expression in cultured cells from the nervous system. , 1972, The Journal of biological chemistry.

[39]  B. Oderfeld‐Nowak,et al.  STANDARDIZATION OF A RADIOCHEMICAL ASSAY OF CHOLINE ACETYLTRANSFERASE AND A STUDY OF THE ACTIVATION OF THE ENZYME IN RABBIT BRAIN , 1971, Journal of neurochemistry.

[40]  B. Case.  Simplified mounting of frozen sections of brain; drying and CHCl3 extraction prior to Nissl staining. , 1969, Stain technology.

[41]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[42]  J. Chen,et al.  Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. , 1994, Progress in brain research.

[43]  J. Coyle,et al.  Developmental time course and ionic dependence of kainate-mediated toxicity in rat cerebellar granule cell cultures. , 1991, The Journal of pharmacology and experimental therapeutics.

[44]  C. Epstein,et al.  Attenuation of glutamate-induced neuronal swelling and toxicity in transgenic mice overexpressing human CuZn-superoxide dismutase. , 1990, Acta neurochirurgica. Supplementum.

[45]  L. Flohé,et al.  Superoxide dismutase assays. , 1984, Methods in enzymology.

[46]  Jeffrey D. Rothstein,et al.  Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex , 1996, Annals of neurology.